摘要 |
<p>The present invention relates to muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors. Also provided herein are pharmaceutical compositions comprising one or more muscarinic receptor antagonists and at least one or more therapeutic agent selected from histamine antagonists, corticosteroids, beta agonists, leukotriene antagonists, EGFR kinase inhibitors, PAF antagonists, 5-lipoxygenase inhibitors, chemokine inhibitors, PDE-4 inhibitors or p38 MAP Kinase inhibitors.</p> |
申请人 |
RANBAXY LABORATORIES LIMITED;KUMAR, NARESH;KAUR, KIRANDEEP;GARG, MALVIKA;PALLE, VENKATA, P.;SALMAN, MOHAMMAD;RAY, ABHIJIT;GUPTA, SUMAN;MALHOTRA, SHIVANI;SHIRUMALLA, RAJKUMAR |
发明人 |
KUMAR, NARESH;KAUR, KIRANDEEP;GARG, MALVIKA;PALLE, VENKATA, P.;SALMAN, MOHAMMAD;RAY, ABHIJIT;GUPTA, SUMAN;MALHOTRA, SHIVANI;SHIRUMALLA, RAJKUMAR |